Education
About Us
Working with TipRanks
Follow Us
enVVeno Medical (NVNO)
NASDAQ:NVNO
NVNO Stock Chart & Stats
$0.32
-$0.06(-1.92%)
At close: 4:00 PM EST
$0.32
-$0.06(-1.92%)
Day’s Range― - ―
52-Week Range$0.30 - $5.62
Previous CloseN/A
Volume33.14K
Average Volume (3M)589.93K
Market Cap
$6.47M
Enterprise Value$46.94M
Total Cash (Recent Filing)$30.95M
Total Debt (Recent Filing)$791.00K
Price to Earnings (P/E)―
Beta1.90
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding20,216,175
10 Day Avg. Volume395,892
30 Day Avg. Volume589,933
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)1.23
Price to Sales (P/S)0.00
P/FCF Ratio-3.07
Enterprise Value/Market Cap7.26
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-95.03
Enterprise Value/Ebitda-2.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
enVVeno Medical News
NVNO FAQ
What was enVVeno Medical’s price range in the past 12 months?
enVVeno Medical lowest stock price was $0.30 and its highest was $5.62 in the past 12 months.
What is enVVeno Medical’s market cap?
enVVeno Medical’s market cap is $6.47M.
When is enVVeno Medical’s upcoming earnings report date?
enVVeno Medical’s upcoming earnings report date is Feb 26, 2026 which is in 65 days.
How were enVVeno Medical’s earnings last quarter?
enVVeno Medical released its earnings results on Nov 06, 2025. The company reported -$0.225 earnings per share for the quarter, beating the consensus estimate of -$0.3 by $0.075.
Is enVVeno Medical overvalued?
According to Wall Street analysts enVVeno Medical’s price is currently Overvalued.
Does enVVeno Medical pay dividends?
enVVeno Medical does not currently pay dividends.
What is enVVeno Medical’s EPS estimate?
enVVeno Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does enVVeno Medical have?
enVVeno Medical has 20,216,175 shares outstanding.
What happened to enVVeno Medical’s price movement after its last earnings report?
enVVeno Medical reported an EPS of -$0.225 in its last earnings report, beating expectations of -$0.3. Following the earnings report the stock price went down -2.941%.
Which hedge fund is a major shareholder of enVVeno Medical?
Currently, no hedge funds are holding shares in NVNO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
enVVeno Medical
enVVeno Medical Corporation (NVNO) is a healthcare company specializing in the development of innovative medical devices aimed at addressing venous diseases. The company's primary focus is on creating solutions for venous valve disorders, with products designed to improve the quality of life for patients suffering from chronic venous insufficiency (CVI). enVVeno Medical operates in the medical device sector, leveraging advanced research and technology to deliver effective treatment options.
Technical Analysis
Ownership Overview
2.24% Insiders
4.65% Mutual Funds
18.72% Other Institutional Investors
70.36% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---